- Home
- Applications
- europe
- oncologist
Show results for
Refine by
Oncologist Product Applications In Europe
11 applications found
However, with the influx of new treatments also comes an “information avalanche.” Simply put, oncologists are struggling with the sheer volume of information they need to keep track of in order to match each individual patient with the best treatment for their unique needs. ...
ByBrightInsight, Inc based in San Jose, CALIFORNIA (USA)
PLGA nanospheres have already been successfully used in vitro and in clinical trials. Results show that drugs encapsulated in PLGA nanoparticles have superior accumulation in the tumor environment, reduced tumor size and enhanced inhibition of cell proliferation. This is thanks to increased cell penetration and reduced toxicity of encapsulated compounds. Because of the higher accumulation in tumoral areas PLGA nanoparticles are also useful for cancer diagnosis and imaging which has a key role in clinical oncology ...
ByNanovex Biotechnologies based in Llanera, SPAIN
Monitor quality of life and treatment effects to increase overall wellbeing. PROMs have become a prominent topic in healthcare innovation, especially in cancer care, via the direct evaluation of treatment outcomes from the patients' perspective. Patient-Reported Outcomes offer physicians a multitude of insights into cancer care processes through the perspective of the patient. Routine collection of PRO data in oncology can plan a pivotal role in improving clinical outcomes and the overall quality of ...
ByHeartbeat Medical based in Berlin, GERMANY
Natural killer (NK) cells have long been known to play a significant role in the body’s innate immune response. They were first described in the 1970s, but only in the last 15 years has significant progress been made in understanding the complexities and therapeutic potential these cells offer in helping fight cancer and other diseases. Today, we know that NK cells not only detect and identify malignant cancer cells, but they also induce cancer cell death and even help trigger a broader adaptive immune ...
ByKiadis Pharma NV based in Amsterdam, NETHERLANDS
The increasing volume of data for managing medical imaging information in conjunction with the international and national regulations for storage of data can now easily be managed using Picture Archiving and Communication Systems(PACS). The digital management of medical data allows the distribution, digitization (DICOM) and procession of medical images, for specific clinical applications (oncology, radiology, cardiology, etc.) as well as for their backup ...
ByBiotexray S.A based in Athens, GREECE
Microbiotica is using best-in-class clinical data and sample sets coupled with its unrivalled microbiome profiling capability to progress best-in-class therapeutics and biomarkers. Microbiotica has programs in IBD, Immuno-oncology and Gut Epithelial Barrier Repair developing medicines and biomarkers based on microbiota. These programs start with deep metagenomic and culture-based analysis of patient samples and involve advanced bioinformatics and machine learning, to identify highly significant bacterial ...
ByMicrobiotica Limited based in Little Chesterford, UNITED KINGDOM
Healthcare is the primary domain of application of our disinfection technology. In addition to environmental inanimate surfaces and fomites, our systems are particularly suited for the disinfection of non-invasive medical devices whose complex surfaces make their cleaning and pathogens’ eradication particularly challenging. All areas of hospitals and medical specialties can benefit for the use of 99T’s systems, from surgery rooms to transplants units, from patients rooms to surgical theaters, from ...
By99 Technologies S.A. based in Lugano, SWITZERLAND
To date, the classification of cancers has been based solely on the phenotypic and genotypic characteristics of tumor cells. A new paradigm, scientifically well established and recommended by WHO guidelines, relies on the introduction of the immune response as a new prognostic parameter to predict and refine the clinical outcomes of cancer patients. Maximize patient survival rates with an assessment of the tumor immune response. ...
ByVeracyte based in Marseille Cedex 9, FRANCE
The global medical devices sector is undergoing a period of significant transformation largely driven by demographic shifts, evolving patient needs and technological advancements. An ageing population, combined with lifestyle related factors has resulted in a global increase in the prevalence of chronic diseases. As a result, early detection, prevention and improved management of chronic diseases has become an increasing focus for healthcare systems across the ...
ByMorgan Advanced Materials based in Windsor, NORTHERN IRELAND
The low level laser therapy is successfully used in nearly all areas of medicine. Numerous studies and long-term clinical experiences substantiate the efficacy of the low level laser ...
ByHeltschl Medizintechnik GmbH based in Schlüsslberg, AUSTRIA
Monoclonal antibodies (mAbs) are used to treat patients in a variety of conditions such as infectious disease, cancer, and autoimmunity. Discovery of therapeutic antibodies is a laborious process, that depends on high-throughput screening of antibody candidates to determine antigen specificity. Immune repertoire analysis provides accurate, sensitive, and rapid detection of antibody sequences in panning rounds or exposured animal models, accelerating the discovery of ...
ByEnpicom B.V. based in s-Hertogenbosch, NETHERLANDS